insights_auto
Why is 1AE down 15.78%?
Dive Deeperchevron_right
1AE:ETR
argenx SE
€705.60
arrow_downward
-15.78%(-132.20) 1D
Oct 8, 5:35:44 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1AE...
Open
€718.00
High
€739.40
Low
€683.60
Mkt. cap
45.88B
Avg. vol.
65.00
Volume
470.00
P/E ratio
30.18
52-wk high
€922.00
52-wk low
€574.20
EPS
€23.38
No. of employees
2K
Open
€718.00
High
€739.40
Low
€683.60
Mkt. cap
45.88B
Avg. vol.
65.00
Volume
470.00
P/E ratio
30.18
52-wk high
€922.00
52-wk low
€574.20
EPS
€23.38
No. of employees
2K
News stories
From web sources and news partners
Benzinga
·
59 minutes ago
$100 Invested In argenx 5 Years Ago Would Be Worth This Much Today
Pluang
·
3 hours ago
ARGX stock drops 10% after halting Phase 3 tria...
Morningstar
·
3 hours ago
argenx Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into argenx (ARGX)
Stocktwits
·
6 hours ago
IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE